Tolvaptan Improves Contrast-Induced Acute Kidney Injury.
Chunyang XuXu HuangGaoliang YanDong WangMeijuan HuChengchun TangPublished in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2022)
TOL can improve CI-AKI by activating the Nrf2/HO-1 signaling pathway, inhibiting oxidative stress response, and reducing tubular cell apoptosis.